Subsequently, PROK1 was found to be strongly expressed in a number of malignant tumors including prostate cancer, neuroblastoma, pancreatic duct cancer, thyroid cancer, and colorectal cancer, and a relationship with the level of malignancy was confirmed [25–32]. Here, PROK1 is linked to prostate cancer.